Contract notice
Section I: Contracting
authority
I.1) Name and addresses
Department of Health and Social Care
39 Victoria Street
London
SW1H 0EU
UK
Contact person: Jay Bains
E-mail: ccsinbox@dhsc.gov.uk
NUTS: UKI32
Internet address(es)
Main address: https://www.gov.uk/government/organisations/department-of-health-and-social-care
Address of the buyer profile: https://www.gov.uk/government/organisations/department-of-health-and-social-care
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://health-family.force.com/s/Welcome
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be sent to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://health-family.force.com/s/Welcome
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
DHSC: PCP: Evidence Summaries (4 lots) FY 24/25
Reference number: C294820
II.1.2) Main CPV code
73200000
II.1.3) Type of contract
Services
II.1.4) Short description
The UK National Screening Committee (UK NSC) advises Ministers and the NHS in the 4 UK countries on all aspects of screening. The UK NSC makes recommendations on whether or not to introduce screening programmes for over 100 conditions. The evidence team, part of the UK NSC Secretariat, hosted by the Department of Health and Social Care, is responsible for managing the evidence review process to ensure UK NSC recommendations remain up to date.<br/><br/>The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries.Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises.<br/><br/>This contract has been divided into 4 lots. Each lot corresponds to the following lots<br/>Lot 1 Biliary atresia <br/>Lot 2 Group B strep<br/>Lot 3 Breast Risk Stratification<br/>Lot 4 Targeted Screening<br/>Contract Project Reference: C294820<br/>Contract term: 9 months with the option to extend for up to further 2 months.<br/>Estimated contract value (including extensions) for all the lots (4) is: £248,264 (excluding VAT), £297,916.80 (inclusive of VAT). Each lot (evidence maps) estimated value is: £62,066 (excluding VAT), £74,479.20 (inclusive of VAT)<br/><br/>The contracting authority considers that this future opportunity may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.<br/><br/>The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.<br/>To find this opportunity in the eTendering system, select “Find Opportunities” and then search by project number or title. Once you have found the Opportunity, press the ‘Register Interest’ button to register your interest. This will make the project to appear on ‘My proposals and quotes’. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.<br/><br/>Deadline for submission: 21st October 2024 at 12 noon
II.1.5) Estimated total value
Value excluding VAT:
248 264.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
Yes
Tenders may be submitted for all lots
Maximum number of lots that may be awarded to one tenderer: 2
II.2) Description
Lot No: 1
II.2.1) Title
Lot 1-Biliary atresia
II.2.2) Additional CPV code(s)
73200000
II.2.3) Place of performance
NUTS code:
UKI32
II.2.4) Description of the procurement
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot Lot 1 Biliary atresia
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
62 066.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 9
This contract is subject to renewal: Yes
Description of renewals:
Additional 2 months at the sole discretion of the Authority and no additional cost.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Lot 2-Group B strep
II.2.2) Additional CPV code(s)
73200000
II.2.3) Place of performance
NUTS code:
UKI32
II.2.4) Description of the procurement
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 2 Group B strep
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
62 066.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 9
This contract is subject to renewal: Yes
Description of renewals:
Additional 2 months at the sole discretion of the Authority and no additional cost.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
Lot 3-Decision analytic model for risk stratification in breast cancer screening
II.2.2) Additional CPV code(s)
73200000
II.2.3) Place of performance
NUTS code:
UKI32
II.2.4) Description of the procurement
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 3 Decision Analytic Model for Risk Stratification
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
62 066.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 9
This contract is subject to renewal: Yes
Description of renewals:
Additional 2 months at the sole discretion of the Authority and no additional cost.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 4
II.2.1) Title
Lot 4-Targeted Screening
II.2.2) Additional CPV code(s)
73200000
II.2.3) Place of performance
NUTS code:
UKI32
II.2.4) Description of the procurement
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 4 Targeted Screening
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
62 066.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 9
This contract is subject to renewal: Yes
Description of renewals:
Additional 2 months at the sole discretion of the Authority and no additional cost.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2024/S 000-018132
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
21/10/2024
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 6 (from the date stated for receipt of tender)
IV.2.7) Conditions for opening of tenders
Date:
21/10/2024
Local time: 12:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.3) Additional information
The UK National Screening Committee (UK NSC) advises Ministers and the NHS in the 4 UK countries on all aspects of screening. The UK NSC makes recommendations on whether or not to introduce screening programmes for over 100 conditions. The evidence team, part of the UK NSC Secretariat, hosted by the Department of Health and Social Care, is responsible for managing the evidence review process to ensure UK NSC recommendations remain up to date.<br/><br/>The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries.Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises.<br/><br/>This contract has been divided into 4 lots. Each lot corresponds to the following lots<br/>Lot 1 Biliary atresia <br/>Lot 2 Group B strep<br/>Lot 3 Breast Risk Stratification<br/>Lot 4 Targeted Screening<br/>Contract Project Reference: C294820<br/>Contract term: 9 months with the option to extend for up to further 2 months.<br/>Estimated contract value (including extensions) for all the lots (4) is: £248,264 (excluding VAT), £297,916.80 (inclusive of VAT). Each lot (evidence maps) estimated value is: £62,066 (excluding VAT), £74,479.20 (inclusive of VAT)<br/><br/>The contracting authority considers that this future opportunity may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.<br/><br/>The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.<br/>To find this opportunity in the eTendering system, select “Find Opportunities” and then search by project number or title. Once you have found the Opportunity, press the ‘Register Interest’ button to register your interest. This will make the project to appear on ‘My proposals and quotes’. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.<br/><br/>Deadline for submission: 21st October 2024 at 12 noon
VI.4) Procedures for review
VI.4.1) Review body
The High Court
The Strand
London
WC2A 2LL
UK
Internet address(es)
URL: https://www.judiciary.uk/courts-and-tribunals/high-court/
VI.4.2) Body responsible for mediation procedures
The High Court
Strand
London
WC2A 2LL
UK
E-mail: generaloffice@administrativecourtoffice.justice.gov.uk
Internet address(es)
URL: https://www.gov.uk/courts-tribunals
VI.4.4) Service from which information about the review procedure may be obtained
The High Court
Strand
London
WC2A 2LL
UK
E-mail: generaloffice@administrativecourtoffice.justice.gov.uk
Internet address(es)
URL: https://www.gov.uk/courts-tribunals
VI.5) Date of dispatch of this notice
09/09/2024